Epidemiology and Prevention

[1]  Mike Rayner,et al.  Cardiovascular disease in Europe: epidemiological update 2016 (vol 37, pg 3232, 2017) , 2019 .

[2]  M. Rayner,et al.  Cardiovascular disease in Europe: epidemiological update 2016. , 2016, European heart journal.

[3]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2012: a synthetic analysis. , 2016, The Lancet. Global health.

[4]  M. Ebell,et al.  Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[5]  A. Schneider,et al.  Benefits and Risks of Cervical Cancer Screening , 2014, Oncology Research and Treatment.

[6]  Eugenio Paci,et al.  European Breast Cancer Service Screening Outcomes: A First Balance Sheet of the Benefits and Harms , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[7]  J. Boehm,et al.  Age and cancer risk: a potentially modifiable relationship. , 2014, American journal of preventive medicine.

[8]  V. del Marmol,et al.  Priorities and challenges for skin cancer prevention in Europe: an expert survey , 2013, Melanoma research.

[9]  J. Gohagan,et al.  Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. , 2011, JAMA.

[10]  Eugenio Paci,et al.  A pooled analysis of interval cancer rates in six European countries , 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[11]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[12]  A. Miller,et al.  Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.

[13]  Peter C Gøtzsche,et al.  Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends , 2009, BMJ : British Medical Journal.

[14]  B. Kramer,et al.  Cancer screening: the clash of science and intuition. , 2009, Annual review of medicine.

[15]  I. Soerjomataram,et al.  Status of implementation and organization of cancer screening in The European Union Member States—Summary results from the second European screening report , 2018, International journal of cancer.

[16]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[17]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[18]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[19]  Amornrat Chanlongbutra.  Foreign birth and Cervical Cancer: Screening, HPV Awareness, and Acculturation in California, Stage and Survival in 18 Surveillance Epidemiology and End Results (SEER) Registries , 2012 .

[20]  Robert A. Smith,et al.  American Cancer Society Guidelines for the Early Detection of Cancer, 2003 , 2003, CA: a cancer journal for clinicians.

[21]  B. Levin,et al.  American Cancer Society Guidelines for the Early Detection of Cancer , 2002, CA: a cancer journal for clinicians.